nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Annoucement
|
|
|
|
22 |
3 |
p. 892-893 |
artikel |
2 |
Antiphospholipid antibody solid phase–based assays: problems and proposed solutions for the 2023 ACR/EULAR classification criteria for antiphospholipid syndrome
|
Huisman, Albert |
|
|
22 |
3 |
p. 874-876 |
artikel |
3 |
Association of pharmacologic thromboprophylaxis with clinically relevant bleeding and hospital-acquired anemia in medical inpatients: the risk stratification for hospital-acquired venous thromboembolism in medical patients study
|
Choffat, Damien |
|
|
22 |
3 |
p. 765-774 |
artikel |
4 |
Between a rock and a hard place: resumption of oral anticoagulant therapy after intracranial hemorrhage
|
Grainger, Brian T. |
|
|
22 |
3 |
p. 594-603 |
artikel |
5 |
Coagulation factor XIII is a critical driver of liver regeneration after partial hepatectomy
|
Wei, Zimu |
|
|
22 |
3 |
p. 620-632 |
artikel |
6 |
Commentary on “Inhibition of cellular activation induced by platelet factor 4 via the CXCR3 pathway ameliorates Japanese encephalitis and dengue viral infections”
|
Drews, Steven J. |
|
|
22 |
3 |
p. 609-612 |
artikel |
7 |
D-dimer Levels for the exclusion of pulmonary embolism: making sense of international guideline recommendations
|
Fan, Bingwen Eugene |
|
|
22 |
3 |
p. 604-608 |
artikel |
8 |
Deficiency of thioredoxin-interacting protein results in age-related thrombocytopenia due to megakaryocyte oxidative stress
|
Shin, Eunju |
|
|
22 |
3 |
p. 834-850 |
artikel |
9 |
Diagnostic value of antibody-induced procoagulant platelets in heparin-induced thrombocytopenia: communication from the ISTH SSC Subcommittee on Platelet Immunology
|
Zlamal, Jan |
|
|
22 |
3 |
p. 860-868 |
artikel |
10 |
Dissecting the rationale for thromboprophylaxis in challenging surgical cases
|
Tafur, Alfonso J. |
|
|
22 |
3 |
p. 613-619 |
artikel |
11 |
Ellinor Peerschke, PhD (1954-2023)
|
Coller, Barry S. |
|
|
22 |
3 |
p. 889-891 |
artikel |
12 |
Evaluating the clinical validity of genes related to hemostasis and thrombosis using the Clinical Genome Resource gene curation framework
|
Ross, Justyne E. |
|
|
22 |
3 |
p. 645-665 |
artikel |
13 |
Extravascular factor IX pool fed by prophylaxis is a true hemostatic barrier against bleeding
|
Leuci, Alexandre |
|
|
22 |
3 |
p. 700-708 |
artikel |
14 |
Genetic and nongenetic drivers of platelet reactivity in healthy Tanzanian individuals
|
Kullaya, Vesla I. |
|
|
22 |
3 |
p. 805-817 |
artikel |
15 |
Group B or not group B? An association between ABO, early mortality, and organ dysfunction in major trauma patients with shock
|
Schofield, Henry |
|
|
22 |
3 |
p. 676-685 |
artikel |
16 |
“Guidance on the Critical Shortage of Sodium Citrate Coagulation Tubes for Hemostasis Testing”: comment from Radišić Biljak et al.
|
Radišić Biljak, Vanja |
|
|
22 |
3 |
p. 886-888 |
artikel |
17 |
Humanization and functional characterization of enhanced coagulation factor IX variants identified through ancestral sequence reconstruction
|
Coyle, Christopher W. |
|
|
22 |
3 |
p. 633-644 |
artikel |
18 |
Inhibition of cellular activation induced by platelet factor 4 via the CXCR3 pathway ameliorates Japanese encephalitis and dengue viral infections
|
Singh, Anamika |
|
|
22 |
3 |
p. 818-833 |
artikel |
19 |
Interplay of fibrinogen αEC globular domains and factor XIIIa cross-linking dictates the extensibility and strain stiffening of fibrin networks
|
Martinez-Torres, Cristina |
|
|
22 |
3 |
p. 715-726 |
artikel |
20 |
Issue Information
|
|
|
|
22 |
3 |
p. e1-e5 |
artikel |
21 |
Management of catheter-related upper extremity deep vein thrombosis in patients with cancer: a systematic review and meta-analysis
|
Wang, Tzu-Fei |
|
|
22 |
3 |
p. 749-764 |
artikel |
22 |
Mechanisms of action of an investigational new freeze-dried platelet-derived hemostatic product
|
Kuhn, Benjamin J. |
|
|
22 |
3 |
p. 686-699 |
artikel |
23 |
Periprocedural management of direct oral anticoagulants in patients with atrial fibrillation and active cancer
|
Shaw, Joseph R. |
|
|
22 |
3 |
p. 727-737 |
artikel |
24 |
Plasma from patients with vaccine-induced immune thrombotic thrombocytopenia displays increased fibrinolytic potential and enhances tissue-type plasminogen activator but not urokinase-mediated plasminogen activation
|
Keragala, Charithani B. |
|
|
22 |
3 |
p. 785-793 |
artikel |
25 |
Proteomic insights into modifiable risk of venous thromboembolism and cardiovascular comorbidities
|
Yuan, Shuai |
|
|
22 |
3 |
p. 738-748 |
artikel |
26 |
SERPINH1 variants and thrombotic risk among middle-aged and older adults: a population-based cohort study
|
Manderstedt, Eric |
|
|
22 |
3 |
p. 869-873 |
artikel |
27 |
Structural architecture of the acidic region of the B domain of coagulation factor V
|
Mohammed, Bassem M. |
|
|
22 |
3 |
p. 709-714 |
artikel |
28 |
Synergism of red blood cells and tranexamic acid in the inhibition of fibrinolysis
|
Raska, Alexandra |
|
|
22 |
3 |
p. 794-804 |
artikel |
29 |
Targeted long-read sequencing identifies and characterizes structural variants in cases of inherited platelet disorders
|
Zamora-Cánovas, Ana |
|
|
22 |
3 |
p. 851-859 |
artikel |
30 |
The common VWF variant p.Y1584C: detailed pathogenic examination of an enigmatic sequence change
|
Christopherson, Pamela A. |
|
|
22 |
3 |
p. 666-675 |
artikel |
31 |
“The portal vein in patients with cirrhosis is not an excessively inflammatory or hypercoagulable vascular bed, a prospective cohort study”: comment from Liu et al.
|
Liu, Guofeng |
|
|
22 |
3 |
p. 881-883 |
artikel |
32 |
“The portal vein in patients with cirrhosis is not an excessively inflammatory or hypercoagulable vascular bed, a prospective cohort study”: reply
|
Driever, Ellen G. |
|
|
22 |
3 |
p. 884-885 |
artikel |
33 |
The risk for venous thromboembolism and cardiometabolic disorders in offspring from thrombosis-prone pedigrees
|
Zöller, Bengt |
|
|
22 |
3 |
p. 775-784 |
artikel |
34 |
What is in it for the reviewer?
|
Cannegieter, Suzanne C. |
|
|
22 |
3 |
p. 579-580 |
artikel |
35 |
When to use tranexamic acid for the treatment of major bleeding?
|
McQuilten, Zoe K. |
|
|
22 |
3 |
p. 581-593 |
artikel |
36 |
“Women with severe postpartum hemorrhage have a decreased endogenous thrombin potential before delivery”: Comment from Mishima et al.
|
Mishima, Yuko |
|
|
22 |
3 |
p. 877-878 |
artikel |
37 |
“Women with severe postpartum hemorrhage have a decreased endogenous thrombin potential before delivery”: reply
|
de Moreuil, Claire |
|
|
22 |
3 |
p. 879-880 |
artikel |